Hoffmann, BA; Brachmann, J; Andresen, D et al.
Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation RegistryHEART RHYTHM. Bd. 8. H. 7. 2011 S. 981-987
Schuhmacher, S; Foretz, M; Knorr, M et al.
alpha 1AMP-Activated Protein Kinase Preserves Endothelial Function During Chronic Angiotensin II Treatment by Limiting Nox2 UpregulationARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 31. H. 3. 2011 S. 560-566
Kolbel, T; Larena-Avellaneda, A; Carpenter, SW et al.
Alternative access routes to the abdominal and thoracic aorta for aortic stent treatmentGEFASSCHIRURGIE. Bd. 16. H. 3. 2011 S. 160-167
Akimoto, K; Klinkhardt, U; Zeiher, A et al.
Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation ParametersJOURNAL OF CLINICAL PHARMACOLOGY. Bd. 51. H. 6. 2011 S. 805-818
Prinz, N; Clemens, N; Strand, D et al.
Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cellsBLOOD. Bd. 118. H. 8. 2011 S. 2322-2332
Rossig, L; Genth-Zotz, S; Rau, M et al.
Argatroban for elective percutaneous coronary intervention: The ARG-E04 multi-center studyINTERNATIONAL JOURNAL OF CARDIOLOGY. Bd. 148. H. 2. 2011 S. 214-219
Atzler, D; Choe, CU; Zeller, T et al.
Association Between Homoarginine and Acute Ischaemic Stroke - The Role of L-Arginine:Glycine-Amidinotransferase (AGAT)CIRCULATION. Bd. 124. H. 21. 2011 S. -
Atzler, D; Choe, CU; Ojeda, F et al.
Association between L-arginine:glycine-amidinotransferase (AGAT) and homoarginine in humans and genetically modified mice.NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 77-77
Sinning, CR; Sinning, JM; Schulz, A et al.
Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease - Results From the AtheroGene StudyCIRCULATION JOURNAL. Bd. 75. H. 5. 2011 S. 1184-1191
Luotola, K; Pietila, A; Zeller, T et al.
Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetesJOURNAL OF INTERNAL MEDICINE. Bd. 269. H. 3. 2011 S. 322-332